Terms: = Prostate cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614 AND Treatment
3 results:
1. Activation of the kdm5a/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
Du C; Lv C; Feng Y; Yu S
J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
[TBL] [Abstract] [Full Text] [Related]
2. [Evolution of the number of incident cases, stage and first treatments for prostate cancer in France between 2001 and 2016].
Delporte G; Olivier J; Ruffion A; Crouzet S; Cavillon C; Helfrich O; Leroy X; Villers A
Prog Urol; 2019 Feb; 29(2):108-115. PubMed ID: 30638756
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
[TBL] [Abstract] [Full Text] [Related]
